 |
Biota Holdings Limited (ASX:BTA) RSV Licence Assigned to Astrazeneca And Territories Expanded
AUG 25, 2008 11:16 - Article Views: 2,065
Biota Holdings Limited (ASX:BTA) and AstraZeneca (LON:AZN) today announced that the 2005 Collaboration and License Agreement with MedImmune has been assigned to AstraZeneca. AstraZeneca has also secured the rights to a number of Asian and Pacific territories not held by MedImmune under the original agreement and for which Biota will receive an additional US$3.5 million payment, plus future royalties. |
 |
|
|
